- Home
- FTHM vs SXTC Comparison
FTHM vs SXTC Comparison
Compare FTHM & SXTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FTHM
- SXTC
- Stock Information
- Founded
- FTHM 2010
- SXTC 2005
- Country
- FTHM United States
- SXTC China
- Employees
- FTHM N/A
- SXTC N/A
- Industry
- FTHM Real Estate
- SXTC Biotechnology: Pharmaceutical Preparations
- Sector
- FTHM Finance
- SXTC Health Care
- Exchange
- FTHM Nasdaq
- SXTC Nasdaq
- Market Cap
- FTHM 33.6M
- SXTC 34.4M
- IPO Year
- FTHM 2020
- SXTC 2019
- Fundamental
- Price
- FTHM $1.06
- SXTC $1.85
- Analyst Decision
- FTHM Buy
- SXTC
- Analyst Count
- FTHM 1
- SXTC 0
- Target Price
- FTHM $2.50
- SXTC N/A
- AVG Volume (30 Days)
- FTHM 61.8K
- SXTC 726.7K
- Earning Date
- FTHM 08-11-2025
- SXTC 01-01-0001
- Dividend Yield
- FTHM N/A
- SXTC N/A
- EPS Growth
- FTHM N/A
- SXTC N/A
- EPS
- FTHM N/A
- SXTC 20.77
- Revenue
- FTHM $357,816,000.00
- SXTC $1,818,404.00
- Revenue This Year
- FTHM $32.40
- SXTC N/A
- Revenue Next Year
- FTHM $18.04
- SXTC N/A
- P/E Ratio
- FTHM N/A
- SXTC $0.09
- Revenue Growth
- FTHM 5.80
- SXTC 6.78
- 52 Week Low
- FTHM $0.65
- SXTC $0.95
- 52 Week High
- FTHM $3.37
- SXTC $11.92
- Technical
- Relative Strength Index (RSI)
- FTHM 46.00
- SXTC 51.80
- Support Level
- FTHM $1.03
- SXTC $1.84
- Resistance Level
- FTHM $1.36
- SXTC $1.95
- Average True Range (ATR)
- FTHM 0.10
- SXTC 0.29
- MACD
- FTHM -0.03
- SXTC 0.04
- Stochastic Oscillator
- FTHM 13.04
- SXTC 62.50
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, insurance, and Software as a Service (SaaS) offering to brokerages and agents by leveraging proprietary cloud-based software, intelliAgent. The company has three reportable segments namely Real Estate Brokerage, Mortgage and Technology. The brands of the company include Fathom Realty, Dagley Insurance, Encompass Lending, intelliAgent, LiveBy, Real Results, and Verus Title. Majority of revenue is from Real Estate segment.
About SXTC China SXT Pharmaceuticals Inc.
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates its revenue from the People's Republic of China.